Robert A. Winn, MD

Robert A. Winn, MD
Professor, Medicine
​University of Illinois Cancer Center
Chicago, Illinois

Robert Winn, MD, is the associate vice chancellor for community based practice and director of the University of Illinois Cancer Center at the University of Illinois Hospital and Health Sciences System (UI Health). Dr. Winn is a professor of medicine at the University of Illinois at Chicago (UIC), Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine.

As associate vice chancellor, Dr. Winn is responsible for the management of the UI Health Mile Square Health Center, a 13-site Federally Qualified Health Center Network. Mile Square Health Center is dedicated to providing health care for the medically underserved populations in Chicago's South and West Side neighborhoods. The goal of Community Based Practice at UI Health is to integrate and coordinate healthcare for the communities we serve; build a 21st century model of community-based health care providers linked to the mission of our academic health center; and develop meaningful research programs that can be integrated into the community.

The UI Cancer Center is a robust organization comprised of 258 cancer researchers, representing four University of Illinois campuses: Champaign-Urbana, Chicago, Peoria, and Rockford; 11 colleges, including Engineering, Veterinary Medicine, Agriculture, Consumer, and Environmental Sciences and six health sciences colleges of Applied Health Sciences, Dentistry, Nursing, Medicine, Pharmacy, and the School of Public Health. The mission of the Cancer Center is to provide all Illinoisans access to cutting-edge treatment, innovative clinical trials, preventive and community health through creative educational and outreach programs designed to prevent and cure cancer.

Dr. Winn, an NCI-funded physician-scientist, has extensive experience in lung cancer research, both as a clinician and a researcher. Clinically, he is a specialist in pulmonary and critical care with a primary interest in lung cancer, and his laboratory focuses on the tumor predictive role of the Wnt pathway. He has laid the groundwork for developing effective and consistent in vitro and in vivo assays to investigate the tumor suppressive role of Wnt 7a in non-small cell lung cancer.

Dr. Winn received his medical degree from the University of Michigan Medical School in Ann Arbor, Michigan, and completed his medical residency in internal medicine at Rush Presbyterian St. Luke’s Medical Center in Chicago, where he was also a chief resident. He completed his fellowship in pulmonary/critical care medicine at the University of Colorado School of Medicine (CU)/National Jewish Health.

Prior to UI Health, Dr. Winn was an associate professor in the Department of Medicine, Division of Pulmonary/Critical Care Medicine at the University of Colorado Health Sciences Center. He was also an associate dean of admissions for the School of Medicine, vice chair of medicine, for the Department of Medicine, and the senior medical director for the University of Colorado Multidisciplinary Pulmonary Clinic. As a specialist in pulmonary and critical care, he practiced at both the University Hospital and the Veteran Affairs Medical Center in Denver, both in ambulatory medicine and the intensive care unit. Dr. Winn has led and served on a number of diverse committees to develop the next generation of physician-scientists. He has received numerous awards for excellence in teaching, scholarship, leadership, and diversity service.